Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$58,044
+$52,770 QoQ
Shares Held
24,185
+110.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 148 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. LXRX ranks #179 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in LXRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,044 | 24,185 | Shares | Defined | 2026-08-14 | |
| 2025-03-31 | $5,274 | 11,466 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $82,437 | 111,403 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $174,902 | 111,403 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $19,262 | 11,466 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $19,708 | 8,212 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $17,071 | 11,158 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $91,162 | 83,635 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $237,200 | 103,581 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,035 | 30,056 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $50,906 | 26,653 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $63,966 | 26,653 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,057 | 18,848 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $36,712 | 17,566 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $69,210 | 17,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $84,492 | 17,566 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,246 | 6,154 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $32,038 | 5,458 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $17,240 | 5,041 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,259 | 5,041 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,856 | 6,928 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,415 | 7,393 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||